| abstract |
The present invention relates to a solid composition with improved stability and bioavailability, which comprises: a pharmaceutically acceptable amount of a macrolide antibiotic agent, a pharmaceutically acceptable amount of an antimalaria agent, and at least one pharmaceutically acceptable excipient, in an oral administration system, said composition comprising a pharmaceutically solid, granule and/or powder form in one or more phases. |